Skip to main content
Hugel, Inc. logo

Hugel, Inc. — Investor Relations & Filings

Ticker · 145020 ISIN · KR7145020004 KO Manufacturing
Open in API
Filings indexed 499 across all filing types
Latest filing 2023-08-11 Environmental & Social …
Country KR South Korea
Listing KO 145020

About Hugel, Inc.

https://www.hugel-inc.com/

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.

Recent filings

Filing Released Lang Actions
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Environmental & Social Information Classification · 100% confidence The document is a specific regulatory disclosure regarding subcontracting payment methods, payment periods, and dispute resolution mechanisms for Hugel Co., Ltd. This type of detailed operational disclosure, which does not fit into standard financial reporting categories like 10-K or IR, is typically filed as a regulatory disclosure in the Korean market (DART system). Given the specific nature of the data provided, it falls under the 'Regulatory Filings' category.
2023-08-11 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding a 'Clarification of Rumors or Reports' (풍문 또는 보도에 대한 해명). It addresses a specific media report about potential delisting and provides the company's official response that no decision has been made. Since this is a general regulatory announcement regarding market rumors and does not fit into specific categories like M&A or share issues, it is classified as a Regulatory Filing (RNS).
2023-08-10 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Hugel, detailing quarterly financial performance (revenue, operating profit, net income) for 2Q 2023. It is a standard regulatory filing in Korea (DART/KIND system) used to announce preliminary financial results before the full audit is completed. As it provides the initial key financial highlights for the period, it fits the definition of an Earnings Release (ER). Q2 2023
2023-08-09 Korean
대표집행임원변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of Representative Executive Officers (CEO-level positions) for the company Hugel. It details the names of the outgoing and incoming officers, the reasons for the change, the date of the board resolution, and the professional backgrounds of the new appointees. This aligns perfectly with the definition for Board/Management Information (MANG).
2023-08-09 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It is not the presentation itself, but rather a notification of the event and the scheduled release of IR materials. According to the 'Menu vs Meal' rule, announcements of events or report publications are classified as Report Publication Announcements (RPA) or Regulatory Filings (RNS). Given the specific nature of the announcement regarding an IR event, it fits best as a Regulatory Filing (RNS) or an announcement of an event.
2023-08-09 Korean
결산실적공시예고
Report Publication Announcement Classification · 100% confidence The document is a short notice (493 characters) titled '결산실적공시 예고' (Notice of Earnings Release). It informs shareholders of the upcoming date (2023-08-09) for the release of the company's Q2 2023 financial results. Since it is an announcement regarding the timing of a future report rather than the report itself, it falls under the Report Publication Announcement (RPA) category.
2023-08-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.